ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Letetresgene Autoleucel Engineered T Cells in NY-ESO -1 Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

GlaxoSmithKline · 2016
ClinicalTrials.gov · Datasets · License: Public Domain · 2016
Open Source ↗
celltherapyneoplasmsnysmallcelllungcancer
neoplasms, letetresgene autoleucel, adoptive tcr t-cell therapy, ny-eso-1, t cell receptor, non-small cell lung cancer, leukapheresis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 884735
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.